Real-world Safety Profile of Avacincaptad Pegol in the Management of Geographic Atrophy
Our study highlights the safety profile of avacincaptad pegol for GA, with a low incidence of conversion to neovascular AMD, few adverse events, and manageable side effects.
Authors
- Jorge A. Fortun
- Michael Antonietti (ORCID: https://orcid.org/0000-0001-5526-1396)
- Carolina Mercado (ORCID: https://orcid.org/0000-0002-1608-3563)
- Sander R. Dubovy
- Thomas A. Albini
- Jaclyn L. Kovach
- William E. Smiddy
- Stephen G. Schwartz
Institutions
- Massachusetts Eye and Ear Infirmary (US)
- Harvard University (US)
- University of Miami (US)
Publication Details
- Journal
- Ophthalmic surgery, lasers & imaging retina
- Published
- 2026-03-27
- DOI
- https://doi.org/10.3928/23258160-20260305-01
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00